ZOOMLION (01157) announces its financial performance for 2025, with a net profit attributable to shareholders of approximately 4.79 billion yuan, a year-on-year increase of 35.73%. Earnings per share at the end of the period is 0.2 yuan.
China National Heavy Machinery Corporation (01157) announced its performance in 2025, with a total operating revenue of RMB 52.107 billion, a year-on-year increase of 14.58%. The net profit attributable to shareholders of the company in the current year was RMB 4.779 billion, a year-on-year increase of 35.73%. The basic earnings per share were RMB 0.55, and the final dividend was RMB 0.2 per share.
ZOOMLION (01157) announced its performance for 2025, with continuing operating revenue reaching RMB 52.107 billion, a year-on-year increase of 14.58%. The profit attributable to company shareholders for the current year is RMB 4.779 billion, a year-on-year increase of 35.73%. The basic earnings per share is RMB 0.55, with a final dividend of RMB 0.2 per share.
In 2025, the net cash flow from operating activities is RMB 4.573 billion, mainly derived from the sum of pre-tax profits of RMB 5.794 billion, adjusted to reflect interest expenses of RMB 0.596 billion, depreciation and amortization of RMB 1.528 billion, income from the disposal of property, plants and equipment, and intangible assets of RMB 0.548 billion, equity incentive plan expenses of RMB 0.343 billion, and interest income of RMB 0.469 billion. Additionally, it includes an increase in accounts payable and other payable of RMB 6.545 billion, a decrease in financing receivables of RMB 2.131 billion, and an increase in accounts receivable and other receivable of RMB 9.267 billion, as well as income tax paid of RMB 0.919 billion.
The company adheres to the core concept of "using internet thinking for enterprises and extreme thinking for products", anchoring high-quality development goals and continuously advancing towards the strategic direction of "diversification, globalization, and digitization". By driving high-quality development through technological innovation, advancing the transformation to "digitalization, intelligence, and greenization", deepening traditional advantageous sectors, accelerating the growth of emerging business sectors, actively incubating future industries, and expediting the industrialization of intelligent Siasun Robot & Automation. It fully expands global market layout to open up new growth opportunities for the company, helping the enterprise to navigate through economic cycles and achieve stable and sustainable high-quality development.
Related Articles

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.
MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


